Literature DB >> 21172171

Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010.

W Otto1, A Mankertz, S Santibanez, H Saygili, J Wenzel, W Jilg, Wf Wieland, S Borgmann.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 21172171

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


× No keyword cloud information.
  14 in total

1.  Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity.

Authors:  B Halassy; T Kurtović; M Brgles; M Lang Balija; D Forčić
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Investigation of a mumps outbreak in Mongolia, January to April 2011.

Authors:  Igore Munkhjargal; Jargalsaikhan Selenge; Amarjargal Ambaselmaa; Rentseng Tuul; Purevsuren Delgermaa; Sarankhuu Amarzaya; Jantsansengee Baigalmaa; Barhas Byambajav; Dapeng Luo
Journal:  Western Pac Surveill Response J       Date:  2012-12-12

3.  Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus.

Authors:  Pei Xu; Zhuo Li; Dengyun Sun; Yuan Lin; Jianguo Wu; Paul A Rota; Biao He
Journal:  Virology       Date:  2011-06-14       Impact factor: 3.616

4.  Mumps Virus SH Protein Inhibits NF-κB Activation by Interacting with Tumor Necrosis Factor Receptor 1, Interleukin-1 Receptor 1, and Toll-Like Receptor 3 Complexes.

Authors:  Stephanie Franz; Paul Rennert; Maria Woznik; Josephine Grützke; Amy Lüdde; Eva Maria Arriero Pais; Tim Finsterbusch; Henriette Geyer; Annette Mankertz; Nicole Friedrich
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

5.  The V protein of mumps virus plays a critical role in pathogenesis.

Authors:  Pei Xu; Priya Luthra; Zhuo Li; Sandra Fuentes; James Alexander D'Andrea; Jianguo Wu; Steven Rubin; Paul A Rota; Biao He
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

6.  Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011.

Authors:  Anja Takla; Merle M Böhmer; Christina Klinc; Norbert Kurz; Alice Schaffer; Heribert Stich; Petra Stöcker; Ole Wichmann; Judith Koch
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

7.  Mumps virus infection in vaccinated patients can be detected by an increase in specific IgG antibodies to high titres: a retrospective study.

Authors:  S Borgmann; F Schwab; S Santibanez; A Mankertz
Journal:  Epidemiol Infect       Date:  2014-01-15       Impact factor: 4.434

8.  Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

Authors:  M Šantak; M Lang-Balija; J Ivancic-Jelecki; T Košutić-Gulija; S Ljubin-Sternak; D Forcic
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 4.434

9.  Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.

Authors:  Christina Poethko-Müller; Annette Mankertz
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

10.  Protective effect of vaccination against mumps complications, Czech Republic, 2007-2012.

Authors:  Hana Orlíková; Marek Malý; Pavla Lexová; Helena Šebestová; Radomíra Limberková; Lucie Jurzykowská; Jan Kynčl
Journal:  BMC Public Health       Date:  2016-04-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.